Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Thumbnail

Bulimia nervosa in women linked to CVD, death

Bulimia nervosa places women at a significantly greater risk of CVB and death than women who have not been diagnosed with the condition, a JAMA Psychiatry study reveals.

Thumbnail

Taking BP meds at bedtime slashes CVD risk

The largest study of its kind has found that taking blood pressure medication at bedtime—as opposed to first thing in the morning—lowers heart patients’ risk of death and CV-related illness in the long run.

Thumbnail

Breastfeeding could keep diabetes, hypertension at bay

Women who breastfeed for more than one year may be less likely to develop diabetes and hypertension.

Thumbnail

Weight gain puts collegiate athletes at risk of CVD

Weight gain during early training causes cardiovascular problems for collegiate football players.

Thumbnail

Pregnant women could soon self-screen for preeclampsia

Pregnant women may soon be able to assess their own risk of preeclampsia, according to work published in the Journal of Engineering and Science in Medical Diagnostics and Therapy

Thumbnail

Actively commuting to work lowers risk of IHD, stroke

A study of more than 100,000 urban commuters in China suggests that walking or cycling to work can lower people’s risk of ischemic heart disease (IHD) and stroke, even when factoring in the “rather serious air pollution” in the country.

Thumbnail

FDA names Torrent Pharmaceuticals as major player in losartan crisis

The FDA on Oct. 15 issued a warning letter to India-based Torrent Pharmaceuticals, targeting the drug company as one of the primary contributors to the onslaught of BP drug recalls in the past year.

Thumbnail

Angiotensin receptor blockers linked to heightened risk of suicide

A study of thousands of individuals in Canada suggests the use of angiotensin receptor blockers—as opposed to ACE inhibitors—could be linked to an increased risk of suicide and poor mental health.